QIAGEN announces the launch of the QIAstat-Dx Respiratory 4 Plex Flu A-B/RSV/SARS-CoV-2 test to help quickly differentiate patients with common seasonal respiratory infections or those with SARS-CoV-2. This diagnostic tool can help leverage a modular, cartridge-based system to deliver fast results that require no additional sample preparation. The RT-PCR multiplex test detects and differentiates among influenza A and B, respiratory syncytial virus (RSV), and SARS-CoV-2 infections. It aims to streamline the complete molecular testing process—a technician simply loads a clinical sample into a single-use QIAstat-Dx cartridge and places it in the analyzer. With QIAGEN chemistries for sample processing and analysis built in, the QIAstat-Dx instrument delivers results in approximately 1 hour.